Skip to content
Screener

PROCEPT BioRobotics Corporation PRCT Total Revenue

Total Revenue at other companies

TFX
TeleflexTFX
$570.33M+28.9%
Boston Scientific logo
Boston ScientificBSX
$5.44B+7.5%
Intuitive Surgical logo
Intuitive SurgicalISRG
$2.89B+18.5%
Apyx Medical Corporation logo
Apyx Medical CorporationAPYX
$12.49M+32.4%
PDE
Pro-Dex, Inc.PDEX
$19.95M+14.6%
Microbot Medical logo
Microbot MedicalMBOT
$105K—

Segments

By product

See full
Handpieces and other consumables$55.2M+12.3%
System sales and leases$32.47M—
Service$6.84M+36.1%

By geography

See full
U.S.$52.22M—

Other financials

Income statement

See full
Gross profit$62.4M+20.5%
Operating income-$27.4M-23.4%
Net income-$26.9M-37.2%
EPS (diluted)-$0.47-34.3%

Balance sheet

See full
Cash & equivalents$11.4M-96.3%
Total debt$77.5M-2.4%
Total equity$340.1M-11.9%
Total assets$479.4M-6.6%

Cash flow

See full
Operating cash flow-$19.3M-28.0%
CapEx$3.0M+5.4%
Free cash flow-$22.2M-24.4%

Valuation

See full
Market cap$1.15B-25.9%
Enterprise value$1.21B—
P/S3.4×—

Profitability

See full
Gross margin64.2%0.0pp
Operating margin-33.9%+0.5pp
Net margin-32.5%+2.2pp
FCF margin-25.2%-4.6pp

Returns & leverage

See full
Return on equity-30.2%+5.2pp
Debt / equity0.2×0.0×
Current ratio6.5×-2.7×

Where this comes from

Reported directly by PROCEPT BioRobotics Corporation in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: PROCEPT BioRobotics Corporation’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:14 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001588978-26-000030
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Revenue$94,498$79,182$177,631$148,344
Cost of sales32,11927,43661,30452,437
Gross profit62,37951,746116,32795,907
Operating expenses:
Research and development20,10117,63241,56734,034
Selling, general and administrative69,66856,303134,756111,499
Total operating expenses89,76973,935176,323145,533
Loss from operations(27,390)(22,189)(59,996)(49,626)

Item 1. Condensed Consolidated Financial Statements (unaudited)

FAQ

What is PROCEPT BioRobotics Corporation's total revenue?
PROCEPT BioRobotics Corporation (PRCT) reported total revenue of $94.5M in Q2 2026.
How has PROCEPT BioRobotics Corporation's total revenue changed year-over-year?
PROCEPT BioRobotics Corporation's total revenue increased by 19.3% year-over-year, from $79.18M to $94.5M.
What is the long-term trend for PROCEPT BioRobotics Corporation's total revenue?
Over 4 years (2021 to 2025), PROCEPT BioRobotics Corporation's total revenue has grown at a 72.9% compound annual growth rate (CAGR), from $34.47M to $308.05M.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Ask your AI about PROCEPT BioRobotics Corporation's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude